Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 196


Basal Ki67 expression measured by digital image analysis is optimal for prognostication in oral squamous cell carcinoma.

Klimowicz AC, Bose P, Nakoneshny SC, Dean M, Huang L, Chandarana S, Magliocco AM, Wayne Matthews T, Brockton NT, Dort JC.

Eur J Cancer. 2012 Sep;48(14):2166-74. doi: 10.1016/j.ejca.2012.04.010. Epub 2012 Aug 12.


Bax expression measured by AQUAnalysis is an independent prognostic marker in oral squamous cell carcinoma.

Bose P, Klimowicz AC, Kornaga E, Petrillo SK, Matthews TW, Chandarana S, Magliocco AM, Brockton NT, Dort JC.

BMC Cancer. 2012 Aug 1;12:332. doi: 10.1186/1471-2407-12-332.


Loss of DLC1 is an independent prognostic factor in patients with oral squamous cell carcinoma.

Tripathi SC, Kaur J, Matta A, Gao X, Sun B, Chauhan SS, Thakar A, Shukla NK, Duggal R, Choudhary AR, DattaGupta S, Sharma MC, Ralhan R, Siu KW.

Mod Pathol. 2012 Jan;25(1):14-25. doi: 10.1038/modpathol.2011.145. Epub 2011 Oct 14.


Prognostic value of Ki67 from clinically and histologically 'normal' distant mucosa in patients surgically treated for oral squamous cell carcinoma: a prospective study.

Montebugnoli L, Badiali G, Marchetti C, Cervellati F, Farnedi A, Foschini MP.

Int J Oral Maxillofac Surg. 2009 Nov;38(11):1165-72. doi: 10.1016/j.ijom.2009.06.011. Epub 2009 Jul 16.


Oral squamous cell carcinoma: histologic risk assessment, but not margin status, is strongly predictive of local disease-free and overall survival.

Brandwein-Gensler M, Teixeira MS, Lewis CM, Lee B, Rolnitzky L, Hille JJ, Genden E, Urken ML, Wang BY.

Am J Surg Pathol. 2005 Feb;29(2):167-78.


Molecular predictors of locoregional and distant metastases in oropharyngeal squamous cell carcinoma.

Barber BR, Biron VL, Klimowicz AC, Puttagunta L, Côté DW, Seikaly H.

J Otolaryngol Head Neck Surg. 2013 Oct 16;42:53. doi: 10.1186/1916-0216-42-53.


Proliferation indices of phosphohistone H3 and Ki67: strong prognostic markers in a consecutive cohort with stage I/II melanoma.

Nielsen PS, Riber-Hansen R, Jensen TO, Schmidt H, Steiniche T.

Mod Pathol. 2013 Mar;26(3):404-13. doi: 10.1038/modpathol.2012.188. Epub 2012 Nov 23.


Osteopontin expression is an independent factor for poor survival in oral squamous cell carcinoma: a computer-assisted analysis on TMA sections.

Avirović M, Matušan-Ilijaš K, Damante G, Fabrro D, Cerović R, Juretić M, Grahovac B, Jonjić N, Lučin K.

J Oral Pathol Med. 2013 Sep;42(8):620-6. doi: 10.1111/jop.12055. Epub 2013 Feb 25.


Ultra-deep targeted sequencing of advanced oral squamous cell carcinoma identifies a mutation-based prognostic gene signature.

Chen SJ, Liu H, Liao CT, Huang PJ, Huang Y, Hsu A, Tang P, Chang YS, Chen HC, Yen TC.

Oncotarget. 2015 Jul 20;6(20):18066-80.


High-risk human papillomavirus E6/E7 mRNA detection by a novel in situ hybridization assay strongly correlates with p16 expression and patient outcomes in oropharyngeal squamous cell carcinoma.

Ukpo OC, Flanagan JJ, Ma XJ, Luo Y, Thorstad WL, Lewis JS Jr.

Am J Surg Pathol. 2011 Sep;35(9):1343-50. doi: 10.1097/PAS.0b013e318220e59d.


Ki-67 from clinically and histologically "normal" distant mucosa as prognostic marker in early-stage (T1-T2N0) oral squamous cell carcinoma: a prospective study.

Montebugnoli L, Gissi DB, Badiali G, Marchetti C, Cervellati F, Farnedi A, Foschini MP.

J Oral Maxillofac Surg. 2011 Oct;69(10):2579-84. doi: 10.1016/j.joms.2010.10.041. Epub 2011 Feb 3.


CD44 as prognostic factor in oral and oropharyngeal squamous cell carcinoma.

Carinci F, Stabellini G, Calvitti M, Pelucchi S, Targa L, Farina A, Pezzetti F, Pastore A.

J Craniofac Surg. 2002 Jan;13(1):85-9.


Biological markers and DNA flow cytometric analysis in radically resected patients with non-small cell lung cancer. A study of the Perugia Multidisciplinary Team for Thoracic Tumors.

Ludovini V, Pistola L, Gregorc V, Floriani I, Rulli E, Di Carlo L, Semeraro A, Daddi G, Darwish S, Stocchi L, Tofanetti FR, Bellezza G, Sidoni A, Tognellini R, Crinò L, Tonato M.

Tumori. 2008 May-Jun;94(3):398-405.


The prognostic significance of histological features in oral squamous cell carcinoma.

Larsen SR, Johansen J, Sørensen JA, Krogdahl A.

J Oral Pathol Med. 2009 Sep;38(8):657-62. doi: 10.1111/j.1600-0714.2009.00797.x. Epub 2009 Jun 25.


Evaluation of immunohistochemical expression of p53, p21, p27, cyclin D1, and Ki67 in oral and oropharyngeal squamous cell carcinoma.

Perisanidis C, Perisanidis B, Wrba F, Brandstetter A, El Gazzar S, Papadogeorgakis N, Seemann R, Ewers R, Kyzas PA, Filipits M.

J Oral Pathol Med. 2012 Jan;41(1):40-6. doi: 10.1111/j.1600-0714.2011.01071.x. Epub 2011 Aug 29.


Co-expression of p53 and Ki67 and lack of EBV expression in oral squamous cell carcinoma.

Iamaroon A, Khemaleelakul U, Pongsiriwet S, Pintong J.

J Oral Pathol Med. 2004 Jan;33(1):30-6.


FLOT-2 is an independent prognostic marker in oral squamous cell carcinoma.

Wen Q, Alnemah MM, Luo J, Wang W, Chu S, Chen L, Li J, Xu L, Li M, Zhou J, Fan S.

Int J Clin Exp Pathol. 2015 Jul 1;8(7):8236-43. eCollection 2015.


Caspase expression in oral squamous cell carcinoma.

Coutinho-Camillo CM, Lourenço SV, Nishimoto IN, Kowalski LP, Soares FA.

Head Neck. 2011 Aug;33(8):1191-8. doi: 10.1002/hed.21602. Epub 2010 Nov 12.


Independent prognostic factors of 861 cases of oral squamous cell carcinoma in Korean adults.

Choi KK, Kim MJ, Yun PY, Lee JH, Moon HS, Lee TR, Myoung H.

Oral Oncol. 2006 Feb;42(2):208-17. Epub 2005 Oct 24.


Clinical relevance of breast cancer-related genes as potential biomarkers for oral squamous cell carcinoma.

Parris TZ, Aziz L, Kovács A, Hajizadeh S, Nemes S, Semaan M, Chen CY, Karlsson P, Helou K.

BMC Cancer. 2014 May 7;14:324. doi: 10.1186/1471-2407-14-324.

Supplemental Content

Support Center